LBH589B

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LBH589B, covering 2021-07-14 to 2021-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma [Phase 2]